Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06486441 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Endometrial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 640 participants |
| Active Locations | 56 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | January 15, 2026 (Jan 15, 2026) |
As of March 2, 2026: Clinical trial NCT06486441 is currently active_not_recruiting participants. This clinical trial study for endometrial cancer is not currently accepting new participants at 56 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06486441 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 56 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06486441 was last updated Jan 15, 2026 (January 15, 2026). HelloStudys verifies this status automatically.